Detalles de la búsqueda
1.
OPA-15406, a novel, topical, nonsteroidal, selective phosphodiesterase-4 (PDE4) inhibitor, in the treatment of adult and adolescent patients with mild to moderate atopic dermatitis (AD): A phase-II randomized, double-blind, placebo-controlled study.
J Am Acad Dermatol
; 75(2): 297-305, 2016 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-27189825
2.
Pilot trial of low-dose naltrexone and quality of life in multiple sclerosis.
Ann Neurol
; 68(2): 145-50, 2010 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-20695007
3.
Results of a Double-Blind, Randomized, Placebo-Controlled Study of Nabiximols Oromucosal Spray as an Adjunctive Therapy in Advanced Cancer Patients with Chronic Uncontrolled Pain.
J Pain Symptom Manage
; 55(2): 179-188.e1, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-28923526
4.
Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies.
Br J Pain
; 11(3): 119-133, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28785408
Resultados
1 -
4
de 4
1
Próxima >
>>